Global Drugs of Abuse DOA Testing Market Growth Analysis 2024, Forecast To 2033
25 Sep, 2024
The drugs of abuse testing market has witnessed strong growth, increasing from $6.6 billion in 2023 to $7.25 billion in 2024, at a CAGR of 9.8%. This growth is driven by government regulations and heightened awareness around drug testing in various sectors. By 2028, the market is expected to expand to $10.48 billion, with a CAGR of 9.6%. Emerging trends include the use of portable testing devices and advancements in AI for result interpretation.
Major Driver In The Drugs of Abuse DOA Testing Market
The drugs of abuse (DOA) testing market is anticipated to witness growth owing to the increasing demand for drug abuse treatment. Substance abuse, identified by using drug testing, involves the harmful use of substances. As of June 2021, the United Nations Office on Drugs and Crime (UNODC) reported that over 36 million individuals worldwide suffer from drug use disorders. The rising need for drug abuse treatment is driving the market's expansion, with market size estimates for 2023, 2024, and 2028 indicating a positive trajectory.
Request A Free Sample Of The Global Drugs of Abuse DOA Testing Market ReportDrugs of Abuse DOA Testing Market Competitive Landscape
Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Zimmer Biomet Holdings Inc., bioMérieux Inc., Dragerwerk AG & Co. KGaA, Natera Inc., Aegis Sciences Corporation, NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., Homology Medicines Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., Forensic Fluids Laboratories
Key Drugs of Abuse DOA Testing Market Trend
Innovation in the drugs of abuse (DOA) testing market is focusing on the development of advanced products, such as software-as-a-service (SaaS) platforms. SaaS involves hosting applications by a third-party provider and making them accessible over the internet. For example, in December 2023, Merck KGaA, a US-based science and technology company, launched the Addison drug discovery software. This platform enhances drug development and success rates by integrating computer-aided drug design, machine learning, and generative AI to recommend optimal synthesis methods, bridging the gap between virtual molecule design and practical manufacturability.
Get The Full Global Drugs of Abuse DOA Testing Market Report
Drugs of Abuse DOA Testing Market Segmentation
The drugs of abuse (DOA) testing market covered in this report is segmented –
1) By Product And Service: Analyzers, Rapid Testing Devices, Consumables, Laboratory Services
2) By Sample Type: Urine, Hair, Oral Fluid, Breath
3) By Application: Pain Management, Criminal Justice, Workplace Screening
4) By End User: Hospitals, Diagnostic Laboratories, Forensic Laboratories, Other End Users
By Geography:The regions covered in the drugs of abuse (doa) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the drugs of abuse (DOA) testing market in 2023.
The Drugs of Abuse DOA Testing Global Market Report 2024 furnishes information about the global drugs of abuse doa testing market, encompassing details like market size, projections for growth, segmentation across various sectors and regions, and an overview of competitors, including their revenues, profiles, and market shares. Furthermore, the report pinpoints potential opportunities and strategic directions derived from market trends and the strategies adopted by key competitors. The report also offers an assessment of how the COVID-19 pandemic, the Russia-Ukraine conflict, and increasing inflation have affected both global and regional markets, furnishing valuable strategic insights for businesses.